Epidemiology, pathophysiology, and treatment of hypertension in ischaemic stroke patients

Journal of Stroke and Cerebrovascular Diseases

Volumn 22, Issue 7, 2013, Pages

  Hisham, Nur Fatirul ^a   Bayraktutan, Ulvi ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

angiotensin II type 1 receptor blockers; Angiotensin converting enzyme inhibitors; calcium channel blockers; hypertension; ischaemic stroke

Indexed keywords

AMLODIPINE; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; BENIDIPINE; CALCIUM CHANNEL BLOCKING AGENT; CANDESARTAN; CANDESARTAN HEXETIL; CAPTOPRIL; CILNIDIPINE; CYCLIC GMP; DIHYDROPYRIDINE; DILTIAZEM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; GADOLINIUM; GLUCOSE TRANSPORTER 1; INDAPAMIDE; LABETALOL; LOSARTAN; NICARDIPINE; NIMODIPINE; NITRIC OXIDE SYNTHASE; OLMESARTAN; PERINDOPRIL; RAMIPRIL; SARTAN DERIVATIVE; TELMISARTAN; VALSARTAN;

ANTIHYPERTENSIVE THERAPY; ARTERIAL STIFFNESS; ARTICLE; AUTONOMIC NEUROPATHY; BLOOD BRAIN BARRIER; BLOOD CEREBROSPINAL FLUID BARRIER; BRAIN BLOOD FLOW; BRAIN BLOOD VESSEL; BRAIN ISCHEMIA; CELL MEMBRANE; CHEMICAL STRUCTURE; COGNITION; CONGESTIVE HEART FAILURE; CONTROL; DIABETES MELLITUS; DIABETIC NEPHROPATHY; DIASTOLIC BLOOD PRESSURE; DISEASE PREDISPOSITION; DRUG CHOICE; ENDOTHELIUM CELL; ESSENTIAL HYPERTENSION; FOLLOW UP; GENE EXPRESSION; HEALTH CARE PERSONNEL; HEART INFARCTION; HEART MUSCLE CONTRACTILITY; HEART OUTPUT; HEMODYNAMICS; HOSPITALIZATION; HUMAN; HYPERTENSION; LIFESTYLE MODIFICATION; MEAN ARTERIAL PRESSURE; MICROVASCULAR ENDOTHELIAL CELL; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOGENESIS; PATHOPHYSIOLOGY; PATIENT EDUCATION; PREHYPERTENSION; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; REDUCTION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RISK FACTOR; SMOKING; STRESS; STROKE PATIENT; SUBARACHNOID HEMORRHAGE; SYSTOLIC HYPERTENSION; THORAX PAIN; TRANSIENT ISCHEMIC ATTACK; VASCULAR RESISTANCE; VASCULAR SMOOTH MUSCLE;

ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; HYPERTENSION; ISCHAEMIC STROKE;

BRAIN ISCHEMIA; HUMANS; HYPERTENSION; INCIDENCE; PREVALENCE; STROKE;

EID: 84885976931     PISSN: 10523057     EISSN: 15328511     Source Type: Journal    
DOI: 10.1016/j.jstrokecerebrovasdis.2012.05.001     Document Type: Review

References (77)

1. P.M. Rothwell The high cost of not funding stroke research: A comparison with heart disease and cancer Lancet 357 2001 1612 1616
2. J. Bamford, P. Sandercock, and M. Dennis Classification and natural history of clinically identifiable subtypes of cerebral infarction Lancet 337 1991 1521 1526
3. S. Kumar, M.H. Selim, and L.R. Caplan Medical complications after stroke Lancet Neurol 9 2010 105 118
4. M. Santos, E. Kovari, and G. Gold The neuroanatomical model of post-stroke depression: Towards a change of focus? J Neurol Sci 283 2009 158 162
5. Ö. Saka, A. McGuire, and C. Wolfe Cost of stroke in the United Kingdom Age Ageing 38 2009 27 32
6. L.B. Goldstein, C.D. Bushnell, and R.J. Adams Guidelines for the primary prevention of stroke. A guideline for healthcare professionals from the American Heart Association/American Stroke Association Stroke 42 2011 517 584
7. M. Brainin, and W.-D. Heiss Textbook of stroke medicine. 2010 Cambridge University Press New York
8. P. Harmsen, G. Lappas, and A. Rosengren Long-term risk factors for stroke: Twenty-eight years of follow-up of 7457 middle-aged men in Goteborg, Sweden Stroke 37 2006 1663 1667
9. B.M. Kissela, J. Khoury, and D. Kleindorfer Epidemiology of ischemic stroke in patients with diabetes Diabet Care 28 2005 355 359
10. G. Mancia, G. De Backer, and A. Dominiczak 2007 Guidelines for the management of arterial hypertension Eur Heart J 28 2007 1462 1536
11. A.I. Qureshi, F. Suri, and J. Kirmani Prevalence and trends of prehypertension and hypertension in United States: National Health and Nutrition Examination Surveys 1976 to 2000 Med Sci Monit 11 2005 CR403 CR409
12. B. Johansson Hypertension mechanisms causing stroke Clin Exp Pharmacol Physiol 26 1999 563 565
13. W.J. Jones, L.S. Williams, and A. Bruno Hypertension and cerebrovascular disease Sem Cerebrovasc Dis Stroke 3 2003 144 154
14. Y. Agmon, B.K. Khandheria, and I. Meissner Independent association of high blood pressure and aortic atherosclerosis: A population-based study Circulation 102 2000 2087 2093
15. J. van der Linden, P. Bergman, and L. Hadjinikolaou The topography of aortic atherosclerosis enhances its precision as a predictor of stroke Ann Thoracic Surg 83 2007 2087 2092
16. T.-C. Su, J.-S. Jeng, and K.-L. Chien Hypertension status is the major determinant of carotid atherosclerosis: A community-based study in Taiwan Stroke 32 2001 2265 2271
17. B. Lernfelt, M. Forsberg, and C. Blomstrand Cerebral atherosclerosis as predictor of stroke and mortality in representative elderly population Stroke 33 2002 224 229
18. M. Hollander, M.L. Bots, and A.I. Del Sol Carotid plaques increase the risk of stroke and subtypes of cerebral infarction in asymptomatic elderly: The Rotterdam study Circulation 105 2002 2872 2877
19. J.M. Wardlaw, F. Doubal, and P. Armitage Lacunar stroke is associated with diffuse blood-brain barrier dysfunction Ann Neurol 65 2009 194 202
20. J.-M. Lee, G. Zhai, and Q. Liu Vascular permeability precedes spontaneous intracerebral hemorrhage in stroke-prone spontaneously hypertensive rats Stroke 38 2007 3289 3291
21. A. Lippoldt, U. Kniesel, and S. Liebner Structural alterations of tight junctions are associated with loss of polarity in stroke-prone spontaneously hypertensive rat blood-brain barrier endothelial cells Brain Res 885 2000 251 261
22. H. Wolburg, J. Neuhaus, and U. Kniesel Modulation of tight junction structure in blood-brain barrier endothelial cells. Effects of tissue culture, second messengers and cocultured astrocytes J Cell Sci 107 1994 1347 1357
23. U. Kniesel, W. Risau, and H. Wolburg Development of blood-brain barrier tight junctions in the rat cortex Dev Brain Res 96 1996 229 240
24. H. Ishida, K. Takemori, and K. Dote Expression of glucose transporter-1 and aquaporin-4 in the cerebral cortex of stroke-prone spontaneously hypertensive rats in relation to the blood-brain barrier function Am J Hypertens 19 2006 33 39
25. H. Al-Sarraf, and L. Philip Effect of hypertension on the integrity of blood brain and blood CSF barriers, cerebral blood flow and CSF secretion in the rat Brain Res 975 2003 179 188
26. J. Castillo, R. Leira, and M.M. García Blood pressure decrease during the acute phase of ischemic stroke is associated with brain injury and poor stroke outcome Stroke 35 2004 520 526
27. E.C. Sandset, P.M.W. Bath, and G. Boysen The angiotensin-receptor blocker candesartan for treatment of acute stroke (SCAST): A randomised, placebo-controlled, double-blind trial Lancet 377 2011 741 750
28. H.P. Adams Jr., G. del Zoppo, and M.J. Alberts Guidelines for the early management of adults with ischemic stroke: A guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: The American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists Circulation 115 2007 e478 e534
29. L. Heitsch, and E.C. Jauch Management of hypertension in the setting of acute ischemic stroke Curr Hypertens Rep 9 2007 506 511
30. H.P. Adams, R.J. Adams, and T. Brott Guidelines for the early management of patients with ischemic stroke: A scientific statement from the stroke council of the American Stroke Association Stroke 34 2003 1056 1083
31. J.-G. Wang, J.A. Staessen, and W.H. Birkenhäger Antihypertensive treatment and prevention of stroke and dementia Semin Cerebrovasc Dis Stroke 3 2003 155 164
32. G. Mancia Prevention and treatment of stroke in patients with hypertension Clin Ther 26 2004 631 648
33. R.L. Sacco, R. Adams, and G. Albers Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack: A statement for healthcare professionals from the American Heart Association/American Stroke Association Council on Stroke: Co-sponsored by the Council on Cardiovascular Radiology and Intervention: The American Academy of Neurology affirms the value of this guideline Circulation 113 2006 e409 e449
34. K.S. Mark, and T.P. Davis Stroke: Development, prevention and treatment with peptidaseinhibitors Peptides 21 2000 1965 1973
35. P. Bentley, and P. Sharma Pharmacological treatment of ischemic stroke Pharmacol Ther 108 2005 334 352
36. V. Papademetriou, C. Farsang, and D. Elmfeldt Stroke prevention with the angiotensin II type 1-receptor blocker candesartan in elderly patients with isolated systolic hypertension: The study on cognition and prognosis in the elderly (SCOPE) J Am Coll Cardiol 44 2004 1175 1180
37. J. Diez Review of the molecular pharmacology of Losartan and its possible relevance to stroke prevention in patients with hypertension Clin Ther 28 2006 832 848
38. B. Williams, P.S. Lacy, and S.M. Thom CAFÉ Investigators; Anglo-Scandinavian Cardiac Outcomes Trial Investigators: CAFÉ Steering and Writing Committee. Differential impact of blood-pressure lowering drugs on central aortic pressure and clinical outcomes: principal results of the Conduit Artery Function Circulation 113 2006 1213 1225
39. A.R. De Caterina, and A.M. Leone The role of beta-blockers as first-line therapy in hypertension Curr Atheroscler Rep 13 2011 147 153
40. B.N. Prichard, J.M. Cruickshank, and B.R. Graham Beta-adrenergic blocking drugs in the treatment of hypertension Blood Press 10 2001 366 386
41. A.R. De Caterina, and A.M. Leone Why beta-blockers should not be used as first choice in uncomplicated hypertension Am J Cardiol 105 2010 1433 1438
42. L.H. Lindholm, B. Carlberg, and O. Samuelsson Should beta blockers remain as first choice in the treatment of primary hypertension? A meta-analysis Lancet 366 2005 1545 1553
43. B. Dahlöf Prevention of stroke in patients with hypertension Am J Cardiol 100 2007 17J 24J
44. B. Dahlöf Prevention of stroke: New evidence Eur Heart J Suppl 11 2009 F33 F38
45. S. Yusuf, H.C. Diener, and R.L. Sacco Telmisartan to prevent recurrent stroke and cardiovascular events New Engl J Med 359 2008 1225 1237
46. G.A. Ford, D. Massey, and S. Ounpuu Effect of telmisartan on cognitive decline following stroke: PRoFESS cognitive sub-study Stroke 40 2009 e274
47. C. Savoia, T. Ebrahimian, and Y. He Angiotensin II/AT2 receptor-induced vasodilation in stroke-prone spontaneously hypertensive rats involves nitric oxide and cGMP-dependent protein kinase J Hypertens 24 2006 2417 2422
48. S. Mukaddam-Daher, A. Menaouar, and P.-A. Paquette Hemodynamic and cardiac effects of chronic eprosartan and moxonidine therapy in stroke-prone spontaneously hypertensive rats Hypertens 53 2009 775 781
49. S. Matsumoto, M. Shimodozono, and R. Miyata Antihypertensive efficacy and cerebral hemodynamic advantage of olmesartan medoxomil compared with amlodipine in poststroke patients [poster 56] Arch Phys Med Rehab 88 2007 e21
50. T. Unger The rationale for choosing telmisartan and ramipril in the ONTARGET programme Eur Heart J Suppl 11 2009 F3 F8
51. K.K. Teo Clinical evidence from ONTARGET: Proven cardio- and vascular protection Eur Heart J Suppl 11 2009 F9 F15
52. J. McMurray, S. Solomon, and K. Pieper The effect of valsartan, captopril, or both on atherosclerotic events after acute myocardial infarction: An analysis of the valsartan in acute myocardial infarction trial (VALIANT) J Am Coll Cardiol 47 2006 726 733
53. J.-M. Bugnicourt, J.-M. Chillon, and S. Canaple Stroke secondary prevention and blood pressure reduction: An observational study of the use of PROGRESS therapy Fund Clin Pharmacol 22 2008 217 222
54. PROGRESS Collaborative Group Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attack Lancet 358 2001 1033 1041
55. J.J. Brugts, T. Ninomiya, and E. Boersma The consistency of the treatment effect of an ACE-inhibitor based treatment regimen in patients with vascular disease or high risk of vascular disease: A combined analysis of individual data of ADVANCE, EUROPA, and PROGRESS trials Eur Heart J 30 2009 1385 1394
56. Y. Hasegawa, K. Shimada, and T. Yamaguchi Efficacy and safety of diuretics in combination with perindopril in hypertensive stroke patients: Results of the Japan Perindopril and Diuretics on Cerebrovascular Disease Study (J-PADOC) Blood Press Suppl 1 2010 10 16
57. S. Yusuf, P. Sleight, and J. Pogue Effects of an angiotensin-converting- enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients New Engl J Med 342 2000 145 153
58. M. Gianni, J. Bosch, and J. Pogue Effect of long-term ACE-inhibitor therapy in elderly vascular disease patients Eur Heart J 28 2007 1382 1388
59. M.R. Law, J.K. Morris, and N.J. Wald Use of blood pressure lowering drugs in the prevention of cardiovascular disease: Meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies BMJ 338 2009 1665 1684
60. J.G. Wang, Y. Li, and S.S. Franklin Prevention of stroke and myocardial infarction by amlodipine and angiotensin receptor blockers: A quantitative overview Hypertens 50 2007 181 188
61. N. Chen, M. Zhou, and M. Yang Calcium channel blockers versus other classes of drugs for hypertension Cochrane Database Syst Rev 8 2010 CD003654
62. A.V. Stanton, J.N. Chapman, and J. Mayet Effects of blood pressure lowering with amlodipine or lisinopril on vascular structure of the common carotid artery Clin Sci 101 2001 455 464
63. K. Takei, N. Araki, and T. Ohkubo Comparison of the anti-hypertensive effects of the L/N-type calcium channel antagonist cilnidipine, and the L-type calcium channel antagonist amlodipine in hypertensive patients with cerebrovascular disease Intern Med 48 2009 1357 1361
64. F. Angeli, P. Verdecchia, and G.P. Reboldi Calcium channel blockade to prevent stroke in hypertension: A meta-analysis of 13 studies with 103,793 subjects Am J Hypertens 17 2004 817 822
65. J.M. Wright, and V.M. Musini First-line drugs for hypertension Cochrane Database Syst Rev 3 2009 CD001841
66. S. Laurent Combination therapy in hypertension: Where do we stand J Hypertens 28 2010 e611
67. F. Amenta, A. Lanari, and F. Mignini Nicardipine use in cerebrovascular disease: A review of controlled clinical studies J Neurol Sci 283 2009 219 223
68. M. Matsubara, O. Akizuki, and J.-I. Ikeda Benidipine, an anti-hypertensive drug, inhibits reactive oxygen species production in polymorphonuclear leukocytes and oxidative stress in salt-loaded stroke-prone spontaneously hypertensive rats Eur J Pharmacol 580 2008 201 213
69. D.R. Lisk, J.C. Grotta, and L.M. Lamki Should hypertension be treated after acute stroke? A randomised controlled trial using single photon emission computed tomography Arch Neurol 50 1993 855 862
70. S.C. Fagan, A. Kozak, and W.D. Hill Hypertension after cerebral ischemia: Candesartan provides neurovascular protection J Hypertens 24 2006 535 539
71. W. Kozak, A. Kozak, and M.H. Johnson Vascular protection with candesartan after experimental acute stroke in hypertensive rats: A dose-response study J Pharmacol Exp Ther 326 2008 773 782
72. J. Schrader, S. Luders, and A. Kulschewski The ACCESS study: Evaluation of acute candesartan cilexetil therapy in stroke survivors Stroke 34 2003 1699 1703
73. N.G. Wahlgren, D.G. MacMahon, and J. DeKeyser Intravenous Nimodipine West European Stroke Trial (INWEST) of nimodipine in the treatment of acute ischaemic stroke Cerebrovasc Dis 4 1994 204 210
74. N. Ahmed, P. Nasman, and N.G. Wahlgren Effect of intravenous nimodipine on blood pressure and outcome after acute stroke Stroke 31 2000 1250 1255
75. N. Ahmed, and N.G. Wahlghren High initial blood pressure after acute stroke is associated with poor functional outcome J Intern Med 249 2001 467 473
76. ENOS Trial Investigators Glyceryl trinitrate vs. control, and continuing vs. stopping temporarily prior antihypertensive therapy, in acute stroke: Rationale and design of the Efficacy of Nitric Oxide in Stroke (ENOS) trial (ISRCTN99414122) Int J Stroke 1 2006 245 249
77. C.S. Anderson, Y. Huang, and H.G. Wang Intensive blood pressure reduction in acute cerebral haemorrhage trial (INTERACT): A randomised pilot trial Lancet Neurol 7 2008 391 399